Article | Open | Published:

BMP9 stimulates joint regeneration at digit amputation wounds in mice

Nature Communicationsvolume 10, Article number: 424 (2019) | Download Citation


A major goal of regenerative medicine is to stimulate tissue regeneration after traumatic injury. We previously discovered that treating digit amputation wounds with BMP2 in neonatal mice stimulates endochondral ossification to regenerate the stump bone. Here we show that treating the amputation wound with BMP9 stimulates regeneration of a synovial joint that forms an articulation with the stump bone. Regenerated structures include a skeletal element lined with articular cartilage and a synovial cavity, and we demonstrate that this response requires the Prg4 gene. Combining BMP2 and BMP9 treatments in sequence stimulates the regeneration of bone and joint. These studies provide evidence that treatment of growth factors can be used to engineer a regeneration response from a non-regenerating amputation wound.


Mammals display poor regenerative capabilities and the typical response to traumatic injury is fibrotic healing1,2. One strategy to enhance mammalian regenerative responses is to use developmental agents to re-initiate morphogenesis at non-regenerative amputation wounds3, and this strategy has been used successfully to stimulate bone regeneration with targeted treatment of bone morphogenetic protein 2 (BMP2) or BMP74,5,6,7,8. Transient treatment of the amputation wound with BMP2 induces formation of an endochondral ossification center that organizes the regeneration response of the amputated stump bone4,5. This induced regeneration response elongates the stump bone but fails to regenerate amputated distal structures such as the joint and the next distal skeletal element. A major next step in enhancing mammalian regeneration is to address regeneration of a joint, a structure that contains articular cartilage which displays poor regenerative capabilities9. During joint development the formation of the synovial cavity is central to joint morphogenesis10, and synovial cavity formation fails in digits that lack the BMP2 antagonist Noggin11, suggesting that regulation of BMP signaling is required for joint morphogenesis. To investigate joint morphogenesis and whether mammalian joints can regenerate, we have focused on a BMP family member, BMP9, which is specifically expressed by interzone cells of the forming synovial cavity and lacks a Noggin binding domain12. We hypothesize that BMP9 can act as a regenerative agent to stimulate joint regeneration at a non-regenerative amputation by re-initiating joint morphogenesis.

Here we demonstrate that treating non-regenerative digit amputation wounds with BMP9 stimulates the regeneration of joint structures. The regenerated joint includes a synovial cavity and a skeletal element lined with articular cartilage that articulates with the amputated bone stump. Further, we show that BMP9-induced joint regeneration requires the proteoglycan 4 (Prg4) gene. Lastly, we demonstrate that the sequential treatment of BMP2 followed by BMP9 stimulates the regeneration of bone and joint by cells that would otherwise undergo fibrotic healing. Taken together, our findings demonstrate that growth factor treatment can be used to overcome mammalian regenerative defects, and provides further evidence that regenerative failure in mammals is associated with a defective wound environment.


Exogenous BMP9 stimulates regeneration of joint structures

Bmp9 is predominately expressed by the embryonic liver, but during limb development, Bmp9 is expressed by interzone cells during late stages of digit joint formation (Fig. 1a; Supplementary Fig. 1a). This expression is restricted to cells involved with cavitation to form the synovial cavity and is transient: Bmp9 is not expressed prior to joint formation nor is it expressed after the joint is complete (Supplementary Fig. 1b-d). Since joint formation fails in mice lacking the BMP antagonist Noggin, and BMP9 is refractory to Noggin inhibition, its expression during joint morphogenesis raised the possibility that BMP9 can act as a regenerative agent to stimulate joint regeneration.

Fig. 1
Fig. 1

Bone morphogenetic protein 9 (BMP9) stimulates regeneration of joint structures. a Bmp9 transcripts are localized to digit joints undergoing cavitation (arrowhead) in E18.5 embryos. b P2 level amputation of neonatal digits is used to test for induced regeneration. Following amputation (red line) at postnatal day 3 (PN3), epidermal closure is completed 4 days later (PN7), and an agarose microcarrier bead (blue dot) is implanted between the wound epidermis and the stump. c Microcomputed tomography (µCT) rendering of a BMP9-treated digit showing regeneration of a skeletal element articulating with the stump after 4 weeks (PN35). d Mallory trichrome staining of BMP9-treated digit 9 weeks after BMP9 treatment (PN70). Regenerated skeletal element (arrow) forms a joint-like structure with the digit stump. Articular cartilage of the P1/P2 joint is shown at higher magnification in the inset. e Higher magnification of the inset in (d) shows a cavity (c) separating a layer of articular cartilage (arrowhead) lining the regenerated skeletal element (n) and the stump bone (s). Small patches of articular cartilage (star) form on the stump bone. fj In situ hybridization of cavity (arrow)-forming BMP9-treated digits showing localization of transcripts to the regenerated chondrogenic nodule but not the digit stump (s) 72 h after bead (*) implantation. f Col2a1. g Sox9. h Acan. i Fmod. j Ucma. k, l Immunofluorescence staining of Doublecortin (Dcx) expression. k Immunostaining shows Dcx+ cells (arrowhead) lining the synovial cavity of an uninjured joint at PN10. l Isolated superficial cells of the BMP9-induced nodule express Dcx (arrowhead) 72 h after treatment (PN10). The cavity is outlined with dashed white lines. Dcx+ cells are also observed internal to the superficial layer. mq In situ hybridization of bovine serum albumin (BSA)-treated control digits 72 h after bead implantation showing no expression associated with the amputation wound distal to the stump. m Col2a1. n Sox9. o Acan. p Fmod. q Ucma. rv In situ hybridization of non-cavity-forming BMP9-treated digits showing localization of transcripts to the distal stump 72 h after bead implantation. r Col2a1. s Sox9. t Acan. u Fmod. v Ucma. Right is distal, top is dorsal. Scale bars: a, fj, mv = 100 µm; d = 250 µm; e, k = 50 µm; l = 25 µm

Digit amputation (Fig. 1b) is used as a non-regenerative model system in neonatal and adult mice2,4,5,13. Amputation bisects the sub-terminal phalangeal element (P2), removing the distal part of P2, the terminal phalangeal element (P3) and the intervening P2/P3 joint. Digit amputation results in skeletal truncation and fibrotic healing (Supplementary Fig. 1e) with no indication of a skeletal or joint regenerative response. At the core of induced regeneration studies is the view that cells of the amputation wound possess the necessary information to regenerate all structures removed by amputation, and we have shown that cells of the mouse amputation display this type of positional information4. To treat amputation wounds with a purified growth factor, a single agarose bead is soaked in a high concentration of growth factor and implanted between the wound epidermis and the amputated stump bone. In vitro studies estimate that a single agarose bead delivers 5.5 ng of BMP9 that is released over a 72 h period (Supplementary Fig. 1f), and this delivery vehicle is intended to transiently stimulate cells locally at the amputation wound. BMP9 treatment stimulates the regeneration of a new distal skeletal element that appears to articulate with the stump bone (Fig. 1c) in 51% of the digits (49/96) analyzed using microcomputed tomography (µCT). This observation is significant as a distal skeletal element is not observed in any bovine serum albumin (BSA)-treated control digits (0/29 digits; P < 0.0001). Digits evaluated by histological analysis, not µCT, demonstrate that the regenerated skeletal element is not ectopic, but forms a joint-like articulation with the stump bone that includes a distinct cavity associated with a chondrogenic layer of cells in 61% of the digits (60/98; Supplementary Fig. 2a, d, g, j). In digits maintained for an extended time period, the chondrogenic cell layer differentiates into articular cartilage that is histologically similar to undamaged articular cartilage (Fig. 1d, e). The BMP9-treated digit stump does not form a complete cartilage layer; however, patches of articular chondrocytes can be identified on the stump surface (Fig. 1e). The remaining BMP9-treated digits that lack a regenerated skeletal element (Supplementary Fig. 2b) appear similar to control BSA-treated digits which heal the stump bone with fibrotic tissue (Supplementary Fig. 2c).

BMP9 induces cavitation and chondrogenesis

Histological analysis 72 h following BMP9 treatment identifies two distinct responses: (1) digits that regenerated a chondrogenic nodule and cavity, referred to as cavity-forming digits (Supplementary Fig. 2d), or 2) digits that failed to form a nodule and cavity, referred to as non-cavity-forming digits (Supplementary Fig. 2e). The digit stump of BMP9-treated non-cavity-forming digits at 72 h appears undifferentiated and is capped with a cluster of chondrogenic cells (Supplementary Fig. 2e) that is maintained at 7 days (Supplementary Fig. 2h), but the digit stump is ossified by 14 days (Supplementary Fig. 2k). BMP9-treated cavity-forming digits maintain a chondrogenic nodule at 7 and 14 days following treatment (Supplementary Fig. 2g, j). The fibrotic healing response of amputated digits treated with BSA was similar to previous descriptions (Supplementary Fig. 2f, i, l1).

The chondrogenic nature of the regenerated nodule in cavity-forming digits was confirmed based on expression of Col2a1 transcripts 72 h after BMP9 treatment (Fig. 1f). We also observe expression of other chondrogenic genes known to be associated with the development of articular chondrocytes including Sox914, Aggrecan (Acan)15, Fibromodulin (Fmod)16 and Upper growth plate and cartilage matrix associated protein (Ucma)17 (Fig. 1g–j). In addition, we show that doublecortin (Dcx)18 is expressed by developing articular chondrocytes of the uninjured digit joint (Fig. 1k) and by surface cells of the BMP9-induced nodule 72 h after treatment (Fig. 1l), but not by cells of the BSA-treated digits (Supplementary Fig. 3a). Chondrogenic genes are not expressed by cells of the amputation wound in BSA-treated control digits (Fig. 1m–q). In BMP9-treated non-cavity-forming digits, we find transcripts of Col2a1, Sox9, Acan, Fmod and Ucma up-regulated at the distal end of the stump (Fig. 1r–v) at 72 h. This is consistent with histological studies (Supplementary Fig. 2e) and since BMP9-treated non-cavity-forming digits fail to maintain a chondrogenic layer of cells at the end of the stump (Supplementary Fig. 2b), the induced expression of these chondrogenic genes by BMP9 is not sufficient to drive articular cartilage regeneration on the digit stump. These studies show that BMP9 induces chondrogenic gene expression in all treated digits, but only those digits that formed a cavity regenerate a joint-like structure that includes articular cartilage.

In BMP9-treated cavity-forming digits, Col2a1 expression is maintained by cells of the nodule 7 days after BMP9 treatment (Supplementary Fig. 3b), but these cells do not express Col10a1 transcripts (Supplementary Fig. 3c). Control BSA-treated digits at 72 h and 7 days do not express Col2a1 or Col10a1 (Fig. 1m, Supplementary Fig. 3d-f). ColX expression is observed at 11 days after BMP9 treatment (Supplementary Fig. 3g) and hypertrophic chondrocytes are identified histologically by 14 days (Supplementary Fig. 2j), indicating that the regenerated skeletal element forms by endochondral ossification. These data indicate that BMP9 stimulates the aggregation and differentiation of chondrocytes but their progression to hypertrophic chondrocytes is delayed compared to BMP2-treated digits4. Bromodeoxyuridine (BrdU) incorporation studies indicate that BMP9 stimulates proliferation of cells surrounding the bead at 72 h, as compared to BSA-treated controls, and that the proliferation response is independent of cavity formation (Supplementary Fig. 3h-j). In cavity-forming digits, the nodule is not next to the BMP9 bead and BrdU-labeled chondrocytes are not present, indicating that BMP9 does not stimulate chondrocyte proliferation (Supplementary Fig. 3h). The absence of proliferating chondrocytes and delayed hypertrophic differentiation distinguishes the BMP9 response from BMP2 stimulation of endochondral ossification4.

Prg4 is required for BMP9-induced joint cavitation

All BMP9-treated digits initiate a chondrogenic response, but only digits that also regenerate a cavity form a joint-like structure. This suggests that the cavitation response plays a key role in the joint regeneration response. Prg4 expression is associated with synovial cavity formation during development. Prg4 encodes for the core protein of lubricin, a proteoglycan found in synovial fluid, and its expression correlates with the early evolution of the vertebrate synovial joint19. Prg4 is expressed by the superficial cell layer of articular cartilage and recent studies show that stem/progenitor cells in this layer give rise to all articular cartilage layers20,21. Thus, the cavitation requirement in joint regeneration may be linked to progenitor cells associated with Prg4-expressing superficial cells. During digit development, Prg4 transcripts localize to the digit joint during cavitation (Supplementary Fig. 3k) and is specifically expressed by cells of the superficial cell layer lining the P2/P3 synovial cavity (Fig. 2a). Prg4 is not expressed by cells of BSA-treated control digit amputation (Supplementary Fig. 3l), or by BMP9-treated samples that fail to form a cavity at 72 h (Supplementary Fig. 3m). However, in BMP9-treated cavity-forming digits, Prg4 transcripts are expressed by cells of the induced cavity as well as by some cells of the distal nodule that abut the cavity (Fig. 2b). By 7 days after BMP9 treatment, only cells forming the cavity express Prg4, and the cavity abuts both the P2 stump and the regenerating nodule (Fig. 2c). The expression of Prg4 by cells forming the cavity identify the regenerated cavity as synovial19. At 24 h following BMP9 treatment, a clear cavitation response is not identified; however, we find samples in which clusters of Prg4-expressing cells are associated with regions of reduced cell density (Fig. 2d), suggesting a relationship between induced Prg4 expression and the initiation of cavitation.

Fig. 2
Fig. 2

Proteoglycan 4 (Prg4) is required for bone morphogenetic protein 9 (BMP9)-induced cavitation. ad In situ hybridization for Prg4 expression. a Prg4 is expressed by cells lining the P2/P3 synovial cavity (arrowhead) and forming the superficial layer of the articular cartilage of the neonatal joint at PN10. b In BMP9-treated cavity-forming digits, Prg4 is expressed by cells lining the induced cavity (arrow) and by cells forming the chondrogenic nodule (arrowhead) 72 h after treatment. c At 7 days after treatment with a BMP9 bead, Prg4 is expressed by cells lining the cavity on both the stump side (arrowhead) and the nodule side (arrow). d At 24 h after BMP9 treatment, Prg4 transcripts are found localized in clusters of cells in the wound bed (arrowhead) associated with the initiation of the cavitation response. e, f Control bovine serum albumin (BSA) bead implantation does not induce an articulation response in PRG4+/− (e) or PRG4−/− (f) digit amputations. g BMP9 treatment of PRG4+/- digit amputations induces an articulation response that includes a distal nodule and cavity. h No regeneration response is observed after BMP9 treatment in PRG4−/− mutants. im In situ hybridization of chondrogenic genes expressed at the distal stump in non-cavity-forming PRG4−/− mutant digits 72 h after BMP9 treatment. i Col2a1. j Sox9. k Acan. l Fmod. m Ucma. Distal is to the right and dorsal is to the top; n nodule, c cavity, s stump, * indicates bead. Scale bars: ad, im = 100 µm; eh = 200 µm

To investigate if Prg4 is required for BMP9-induced cavitation, we performed P2 amputations and BMP9 treatment in the Prg4−/− mouse22. Prg4−/− mice form joints indicating that it is not required for joint development; however, mutant joints have reduced articular cartilage surfaces and display a joint degeneration phenotype22,23. Digits of Prg4−/− and Prg4+/− neonates were amputated and treated with BMP9 or BSA after wound closure. BSA treatment did not evoke a regeneration response in Prg4+/ (n = 8 digits, Fig. 2e) or Prg4−/− (n = 4 digits, Fig. 2f) mice. As a positive control, Prg4+/− digits treated with BMP9 regenerated skeletal articulations at a frequency similar to that observed in wild-type mice (Fig. 2g, 50%; n = 24 digits). In contrast, Prg4−/− digits failed to display a BMP9-induced articulation response (Fig. 2h, 0%, n = 32 digits), demonstrating that the Prg4 gene is required for BMP9-induced regeneration of joint structures. The Prg4−/− response is reminiscent of BMP9-treated non-cavity-forming wild-type digits, and hence we investigated whether the BMP9-induced chondrogenic response was dependent on Prg4. Digits were amputated, treated with BMP9 after wound closure, collected 72 h later and analyzed by in situ hybridization. Prg4−/− digits treated with BMP9 failed to form a cavity, but cells at the distal stump did express transcripts for Col2a1, Sox9, Acan, Fmod and Ucma, indicating that the chondrogenic arm of the BMP9 response was intact and is not dependent on Prg4 (Fig. 2i–m). These studies demonstrate that BMP9 treatment of the digit amputation wound induces two distinct events, chondrogenic induction and cavitation. The induction of a chondrogenic response is consistently observed while BMP9-induced cavitation is more variable, and the data support the conclusion that both responses are required for the regeneration of joint structures.

BMP9 stimulates joint regeneration in adult digits

Developing tissues are known to display enhanced regenerative/repair properties when compared to mature adult tissue. To explore the effect of BMP9 treatment on adult digit amputations we used a sol–gel delivery mechanism effective in eliciting a BMP2-induced bone regenerative response5. Using this protocol, the effect of BMP9 on adult digit amputations was tested by applying BMP9 (250 ng) 9 days after amputation. BSA-treated control digits healed without a regenerative response as previously described5. Digits were collected 7 and 14 days after BMP9 treatment and were analyzed for a regenerative response. BMP9 induced a robust chondrogenic response in all of the digits analyzed at 7 days (n = 4). The regenerated cartilage grew well beyond the amputation plane (Fig. 3a) forming a mushroom-shaped cartilage mass that was contiguous with the peripheral callus that forms after digit amputation1. The large cartilaginous callus is composed of chondrocytes embedded in a dense extracellular matrix (Fig. 3b) and cells are immunopositive for Sox9 and Acan (Fig. 3c, d). We did not observe a cavity associated with the chondrogenic response in our samplings at 7 days. The majority of digit samples analyzed at 14 days (n = 4/5) showed a similar but enlarged chondrogenic response compared to digits collected at 7 days. However, one of the digits displayed a milder chondrogenic response that was not associated with the peripheral callus but was distal to the amputated stump and formed a cavity between the stump and the regenerated chondrogenic element (Fig. 3e, f). The stump component of the cavity was differentiated bone, while the cells lining the regenerated distal element were positive for Sox9 and internal cells expressed both Sox9 and Acan (Fig. 3g, h). The regenerated structure was immunonegative for the developmental articular chondrocyte marker, Dcx (Supplementary Fig. 3n). These studies indicate that BMP9 stimulates both a chondrogenic and cavitation response at adult digit amputation wounds, but the chondrogenic arm of the BMP9 response dominates. Nevertheless, the data show that joint-like structures can be induced to regenerate in adult mice.

Fig. 3
Fig. 3

Bone morphogenetic protein 9 (BMP9) stimulates stump chondrogenesis and cavitation in adult digits. a Mallory trichrome staining of an adult BMP9-treated digit harvested at 7 days post implant (DPI) showing induced chondrogenesis is contiguous with the bone stump. b Higher magnification of the inset in (a) of BMP9-induced chondrocytes at 7 DPI. c, d Immunofluorescence staining for the cartilage marker proteins Sox9 and Acan illustrate chondrogenesis contiguous with the stump bone (dashed white lines) at 7 DPI (n nodule, c cavity, s stump). e Mallory trichrome staining of an adult BMP9-treated digit showing cavity and chondrogenic nodule formation at 14 DPI. f Higher magnification of the inset in (e) showing the chondrogenic and cavitation response at 14 DPI. g, h Immunohistochemistry of the 14 DPI cavity-forming BMP9-treated digit. Dashed white lines outline the cavity. g Cells lining the cavity and within the nodule express the cartilage marker protein Sox9. h Acan immunostaining is restricted to cells within the central region of the nodule. Distal is to the right and dorsal is to the top. Scale bars: a, e = 500 µm; b, c, d = 100 µm; fh = 50 µm

Combined regeneration of bone and joint with BMP2 and BMP9

The digit synovial joint is a tri-layered structure consisting of a central cavity with two articular cartilage layers associated with the adjoining bone elements. BMP9 treatment of neonatal digit amputations result in the formation of a synovial cavity and a distal, but not proximal, articular cartilage layer. At the time of amputation, the P2 stump is undergoing ossification and we hypothesize that the differentiation state of the stump limits the response to BMP9. To explore this we took advantage of our previous finding that BMP2 stimulates the formation of an apical population of proliferating chondrocytes that establishes an endochondral ossification center4. In the BMP2 response the apical zone of proliferating chondrocytes are present from 3 to 7 days after BMP2 treatment. Therefore, we carried out studies in which the amputation wound is treated sequentially; first, with BMP2 to induce proliferating chondrocytes and, second, with BMP9 to stimulate joint regeneration (Fig. 4a). These sequential treatment studies (B2–B9) were carried out with a 3- or 7-day interval separating the two treatments to target the proliferating chondrocyte cell population. The 3-day interval stimulated joint regeneration at a frequency similar to BMP9 alone (57/95 (58%), Fig. 4b) and the 7-day interval stimulated regeneration at a significantly higher frequency (56/80 (70%), P = 0.0135). In both series, histological analyses indicated the regeneration of a complete joint structure that included a layer of articular cartilage lining the stump (Fig. 4c). Control studies in which BMP2 treatment was followed by a second treatment with another BMP2 bead stimulated excessive bone growth but not the regeneration of joint structures (Fig. 4d; 0/16 digits). In another control series, amputated digits were treated with BMP9 10 days after amputation and these digits regenerated joint structures that did not involve the digit stump (Fig. 4e, f). Comparing the sequential B2–B9 response with control undamaged digit joints shows that the regenerated cavity consisted of opposing layers of cells that are immunopositive for ColII (Fig. 4g, h), Acan (Fig. 4i, j) and Dcx (Fig. 4k; Fig. 1k), consistent with the regeneration of articular cartilage. The expression of Prg4 transcripts 96 h after B2–B9 treatment confirmed the regeneration of a synovial cavity (Fig. 4l), and expression of Fmod and Ucma by cells of the distal stump confirmed the differentiation of chondrocytes (Fig. 4m, n).

Fig. 4
Fig. 4

Sequential bone morphogenetic protein 2/9 (BMP2/BMP9) treatment stimulates bone and joint regeneration. a Diagram illustrating sequential BMP2 and BMP9 (B2–B9) treatment. A BMP2 bead is implanted at PN7. A BMP9 bead is implanted distal to the induced endochondral ossification center (EOC) at PN10 or PN14. bm All B2–B9 samples are from the 3-day interval study. b microcomputed tomography (µCT) rendering of a B2–B9-regenerate at PN35 identifies a distal articulation. c Mallory trichrome staining of a B2–B9 regenerate showing cartilage capping the stump and surrounding the nodule (n nodule, c cavity, s stump). d µCT rendering of a PN28 regenerate treated with BMP2 at PN7 and PN10 displaying excessive bone growth and no joint formation. e PN28 µCT rendering of a regenerate treated with BMP9 at PN14. Thus, 50% of the digits formed a nodule that articulated with the stump. f Mallory trichrome staining of digit shown in (e). The regenerate formed a cavity and a cartilage-lined nodule but the stump bone lacks a chondrogenic cell layer. gk Immunofluorescence staining for marker proteins expressed by cells lining both sides of regenerated and control joints. The joint cavity is identified by dashed white lines. Red blood cell autofluorescence (yellow) identifies ossifying regions. g ColII (arrowhead) of the B2–B9 induced cavity and h a control digit joint cavity. i Acan (arrowhead) of the B2–B9-induced cavity and j a control digit joint cavity. k Dcx (arrowhead) of the B2–B9-induced cavity. lr In situ hybridization of B2–B9 regenerates (* indicates bead). l Prg4 transcripts are expressed by cells of the regenerated cavity (arrowhead) 96 h after BMP9 treatment. m, n Fmod (arrowhead in m) and Ucma (arrowhead in n) transcripts are expressed in cells of the distal digit stump and the nodule 96 h following BMP9 treatment. o, p Cells of the distal stump (arrowhead) and the regenerated nodule express Col2a1 (o), whereas Col10a1 is not expressed (p) 48 h after BMP9 treatment. q, r Cells of the distal stump (arrowhead) and the regenerated nodule express Col2a1 (q) but only cells of the stump express Col10a1 (r) 96 h after BMP9 treatment. Right is distal, dorsal is top. Scale bars: c = 200 µm; gk = 50 µm; f, lr = 100 µm

B2–B9-treated digits displayed an enhanced joint regeneration response (i.e., two articular cartilage layers) and a higher response frequency, suggesting that BMP2 treatment elevated the BMP9 cavitation response. To explore this further, 72 h after treatment with BMP2, we found a robust Prg4 expression domain associated with the BMP2 bead but without a cavitation response (Supplementary Fig. 3o), indicating that both BMP2 and BMP9 induce Prg4 expression by cells of the amputation wound. However, cavitation only occurs following BMP9 treatment, indicating that Prg4 expression is required but not sufficient to induce cavitation and joint regeneration, and suggests that BMP2 enhances the BMP9 response by enrichment of the Prg4-expressing cell population. Since BMP9 treatment alone stimulated chondrogenesis but delayed hypertrophic differentiation, we explored whether BMP2-induced endochondral ossification of the stump occurs in conjunction with joint regeneration following B2–B9 treatment. Col2a1, but not Col10a1, transcripts are localized to distal stump cells 48 h after BMP9 treatment consistent with an inhibitory effect of BMP9 on hypertrophic chondrocyte differentiation (Fig. 4o, p). At 96 h, however, both Col2a1 and Col10a1 transcripts co-localize to cells of the digit stump (Fig. 4q, r), indicating that endochondral ossification of the stump does occur in conjunction with BMP9-stimulated joint regeneration. Endochondral ossification of the stump was also confirmed based on histological analysis (Supplementary Fig. 3p), and direct measurements of the P2 stump indicated significant skeletal elongation of B2–B9-treated digits compared to BSA controls (B2–B9 = 1.28 mm, n = 32, s.d. = 0.15 vs. BSA = 0.86 mm, n = 21, s.d. = 0.14; P < 0.01). These results demonstrate that BMP2 treatment of the amputation wound stimulates formation of an endochondral ossification center that mediates skeletal growth from the stump, and also establishes a responsive population of apical cells that can participate in joint regeneration if appropriately stimulated. Thus, sequential treatment of the amputation wound with BMP2 and BMP9 successfully integrates bone regeneration with joint regeneration.


BMP9 is a member of the BMP family of growth factors24 produced by the liver25 and present in circulating plasma26. BMP9 is a physiological ligand for activin receptor-like kinase 127 and, like other BMP family members, signals through the phosphorylation of Smad 1/5/828. Unlike other BMP family members, BMP9 is not effected by BMP antagonists such as Noggin12 which suppresses BMP signaling and is necessary for joint morphogenesis11. We show here that Bmp9 is transiently expressed during digit joint cavitation and that BMP9 treatment stimulates joint regeneration. Mutant studies indicate that Bmp9 is not essential for joint formation29; however, redundancy of gene function is frequently observed in joint and skeletal development30,31,32,33 and regenerative events are stimulated by treatment with non-essential gene products4,8,34. BMP9 has been shown to play a role in the regulation of angiogenesis35, liver fibrosis36, osteogenesis37 and chondrogenesis38,39,40,41. During angiogenesis, BMP9 acts in a context-dependent manner, inhibiting neovascularization in a model of age-related macular degeneration42, while stimulating angiogenesis associated with induced osteogenesis43. Similarly, BMP9 inhibits endogenous digit tip regeneration in neonatal mice44, while stimulating the regeneration of joint structures at non-regenerative amputations. Such context-dependent responses indicate that cells associated with the injury response determine the outcome of BMP9 stimulation, thus shifting attention to the cell types participating in endogenous repair/regenerative programs.

The joint is an essential structural component of the musculoskeletal system, but unlike bone and skeletal muscle, joint tissues, particularly articular cartilage, display a limited capacity for repair9. Joint degenerative disorders such as osteoarthritis affect a large portion of the world population and most clinical approaches focus on engineering articular cartilage for transplantation, not on enhancing endogenous regenerative properties45. We have discovered that treating amputation wounds with BMP9 stimulates the regeneration of joint structures, including articular cartilage and synovial cavity. The action of BMP9 on joint regeneration is likely indirect since two independent induction events, chondrogenesis and cavitation, are required. Further, BMP9 morphogenetic activity can occur at a distance from the BMP9 source, while proliferation is stimulated in neighboring cells that are not involved in either response. The requirement of Prg4 by cells undergoing cavitation is consistent with lineage studies identifying stem cells in the superficial layer associated with the synovial cavity as a cell source for all layers of articular cartilage20,21. The differential response of the digit stump versus the regenerated skeletal element suggests that BMP9-induced chondrogenesis plays a supporting role for articular cartilage differentiation by superficial chondrocytes. This conclusion is further supported by B2–B9 studies showing that chondrogenic modification of the stump by BMP2 enhances the BMP9 response. Thus, the endochondral ossification center established by BMP2 generates a chondrogenic template that supports osteoblast differentiation at one end4,5, and articular cartilage differentiation at the other end, and both processes can be stimulated at a non-regenerative amputation wound.

Transient treatment with either BMP2 or BMP9 transforms the mammalian wound healing response in distinct ways to stimulate regeneration. In the case of BMP2, a zone of proliferating chondrocytes differentiate into hypertrophic chondrocytes that forms a template for stump bone regeneration4. BMP2 also enhances cell recruitment by activating the SDF-1/CXCR4 signaling pathway;46 thus, induced skeletal regeneration involves a coordinated response by multiple cell types in the amputation wound. In the case of BMP9 treatment, a coordinated response involving condensation and differentiation of chondrocytes coupled with the formation of a synovial cavity results in the regeneration of joint structures. These two regenerative responses identify discrete morphogenetic programs that can be activated either independently or coordinately within the context of the amputation wound. These findings provide further support for the view that cells of a non-regenerative mammalian amputation wound retain the positional information necessary to re-build structures removed by amputation, and that regenerative failure results from a deficiency of the wound environment that can be extrinsically manipulated to engineer regenerative events.

Materials and methods

Mouse digit amputation and BMP treatment

Pregnant outbred CD1 mice were purchased from Harlan Laboratories (Indianapolis, IN). The Prg4 knockout mice (Prg4tm1Mawa/J) were purchased from the Jackson Laboratory (Bar Harbor, ME). For neonatal studies, digit amputations were carried out on postnatal day 3 (PN3), and treatment of the amputation wound was carried out after wound closure on PN7 as previously described4. Briefly, a single agarose microcarrier bead (Affi-Gel Blue Gel beads, Bio-Rad, Hercules, CA) was used to deliver BMP9, BMP2 or BSA to the amputation wound. Microcarrier beads were soaked with recombinant human BMP9 (500 ng/µl; R&D Systems, Minneapolis, MN), recombinant human BMP2 (500 ng/µl; R&D Systems, Minneapolis, MN) or BSA (0.1% in phosphate-buffered saline) and implanted between the bone stump and wound epidermis as previously described8. For sequential growth factor treatment, amputated digits were treated with a BMP2 bead at PN7 to induce chondrogenic condensation and then treated with a BMP9 bead 3 (PN10) or 7 (PN14) days later. A minimum sample size (n = 8) was determined via power analysis (1−β = 0.8; α = 0.05). The amount of BMP9 delivered by a single agarose bead was estimated in vitro using the BRITER BMP responsive cell line (Kerafast, Inc., Boston, MA). BRITER cells contain a luciferase reporter under the control of the Id1 promoter and provides a readout of Smad mediated signaling. Since BMP9 lacks a Noggin binding site, BRITER cells were used in the presence of Noggin (100 ng/ml; R&D Systems, Minneapolis, MN) to measure BMP9 signaling without background BMP2/4/7 signaling. Different doses of BMP9 in media containing 0.1% fetal bovine serum were used to generate a standard response curve from 0.1 to 50 ng/ml. BRITER cells were incubated with BMP9 for 5 h and the Luciferase Assay System (Promega Corp., Madison, WI) was used to measure luciferase activity. To estimate agarose bead delivery, 30 BMP9 beads were sequentially placed in 1 ml of assay media for 6, 18 and 48 h and luciferase activity was measured. BMP9 released from the beads was determined by comparison to a BMP9 standard response curve. All measurements were carried out in triplicate.

For adult studies, digit amputations were carried out on 2–3-month-old mice as previously described1. The amputation wound was immediately closed with a ventral skin flap that included the P3 fat pad and sealed with Dermabond (Ethicon, Somerville, NJ). BMP treatment was performed using a sol–gel silica-based glass with embedded growth factor implanted between the bone stump and distal skin as previously described5. Amputated digits received a single treatment of BMP9 (250 ng) on 9 days post amputation (9 DPA) and digits were analyzed 7 (16 DPA) and 14 (23 DPA) days later. All studies comply with relevant ethical regulations for animal testing and research, and received ethical approval by the Institutional Animal Care and Use Committees at Tulane University and Texas A&M University.

Tissue processing

Digits were fixed in buffered zinc formalin (Z-Fix, Anatech Ltd, Battle Creek, MI; overnight at room temperature) for histology and immunohistochemistry, or 4% paraformaldehyde (4 oC, overnight) for section in situ hybridization. Decalcification was carried out using Decalcifier I (Surgipath, Leica Biosystems, Richmond, IL). Tissues were processed for paraffin histology as previously described47 and stained with Mallory Trichrome48 or Picro-sirius red49. BrdU labeling to identify proliferating cells was performed as previously described8. For section in situ hybridization, antisense riboprobes were generated using the Digoxigenin-UTP transcription labeling Kit (Roche, Indianapolis, IN) as previously described47. The following complementary DNA fragments were used to generate antisense riboprobes: Bmp9 (707 bp), Prg4 (600 bp), Ucma (363 bp), Fmod (497 bp), Type II Collagen (Col2a1, 500 bp), Type X Collagen (Col10a1, 650 bp) and Sox9 (586 bp). The 2–5 digit samples were analyzed for each time point. Control studies included BSA-treated amputated digits or stage-matched unamputated digits. Sections were either not counterstained or stained with Alizarin Red (Sigma-Aldrich Co., St Louis, MO) and mounted with Permount Mounting Medium (Thermo Fisher Scientific, Waltham, MA). Imaging of histological and in situ hybridization sections was performed using the Olympus BX60 microscope and DP72 camera, with the DP2-BSW software (Olympus America Inc., Center Valley, PA). For immunohistochemical staining, paraffin sections were deparaffinized and rinsed in Tris-buffered saline with Tween® 20 (Sigma-Aldrich Co.). Antigen retrieval was performed using heat (90 oC, 20 min, pH 6 citrate buffer) or proteinase K (10 mg/ml, 27 oC, 12 min, Dako, Carpinteria, CA). Sections were incubated in a blocking solution (1 h, room temperature, Dako) followed by primary antibody (overnight, 4 oC) and secondary antibody (45 min, room temperature). Antibody details are as follows: Collagen II: mouse anti-ColII (Acris Antibodies, San Diego, CA; AF5710, 1:200 dilution), proteinase K, Alexa Fluor® 568 goat anti-mouse IgG secondary antibody (Invitrogen, Carlsbad, CA; AF11004, 1:500 dilution); Collagen X: rabbit anti-ColX (Abcam, Cambridge, UK; AB58632, 1:500 dilution), proteinase K, Alexa Fluor® 488 goat anti-rabbit IgG secondary antibody (Invitrogen, Carlsbad, CA; A11008, 1:500 dilution); Aggrecan: rabbit anti-Acan (EMD Millipore, Billerica, MA; AB1031, 1:300 dilution), heat retrieval, Alexa Fluor® 488 goat anti-mouse IgG secondary antibody (Invitrogen, Carlsbad, CA; A11008, 1:500 dilution); Doublecortin: rabbit anti-Dcx (Abcam, Cambridge, UK; AB207175, 1:200 dilution), heat retrieval, Alexa Fluor® 488 goat anti-rabbit IgG secondary antibody (Invitrogen, Carlsbad, CA; A11008, 1:500 dilution); Sox9: rabbit anti-Sox9 (Abcam; AB185966, 1:500 dilution), heat retrieval, Alexa Fluor® 488 goat anti-mouse IgG secondary antibody (Invitrogen; A11008, 1:500 dilution). Immunostained sections were counterstained with 4′,6-diamidino-2-phenylindole (DAPI; Invitrogen). Slide imaging was performed with the Olympus BX61 fluorescence deconvolution microscope and Slidebook software (Intelligent Imaging Innovations, Inc., Denver, CO).

Microcomputed tomography scans and image processing

To screen for element regeneration after BMP treatment, P2 digits were scanned at PN28, PN35 or PN42 using the vivaCT 40 (SCANCO Medical, Wayne, PA) as previously described50. Digit samples were scanned using high-resolution settings (voxel size 10.5 μm and energy of 55 kVp; 1000 projections per 180o captured at 380 msec using continuous rotation). µCT files were saved as a dicom image stack, and subsequently uploaded to ImageJ to generate images. The BoneJ51 (Version 1.2.1) Optimized Threshold Plugin for ImageJ was used to create three-dimensional renderings. The Mann–Whitney test was used to determine statistical significance for induced -cavity formation after BSA, BMP9, or BMP2+BMP9 treatment. Statistical analysis was performed using GraphPad PRISM (GraphPad Software, La Jolla, CA).

Reporting summary

Further information on experimental design is available in the Nature Research Reporting Summary linked to this article.

Data availability

All relevant data are available from the authors upon request.

Additional information

Journal peer review information: Nature Communications thanks the anonymous reviewers for their contribution to the peer review of this work. Peer reviewer reports are available.

Publisher’s note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.


  1. 1.

    Dawson, L. A. et al. Analogous cellular contribution and healing mechanisms following digit amputation and phalangeal fracture in mice. Regeneration (Oxf.) 3, 39–51 (2016).

  2. 2.

    Turner, N. J., Johnson, S. A. & Badylak, S. F. A histomorphologic study of the normal healing response following digit amputation in C57bl/6 and MRL/MpJ mice. Arch. Histol. Cytol. 73, 103–111 (2010).

  3. 3.

    Dolan, C. P., Dawson, L. A. & Muneoka, K. Digit tip regeneration: merging regeneration biology with regenerative medicine. Stem Cells Transl. Med. 7, 262–270 (2018).

  4. 4.

    Yu, L., Han, M., Yan, M., Lee, J. & Muneoka, K. BMP2 induces segment-specific skeletal regeneration from digit and limb amputations by establishing a new endochondral ossification center. Dev. Biol. 372, 263–273 (2012).

  5. 5.

    Dawson, L. A. et al. The periosteal requirement and temporal dynamics of BMP2-induced middle phalanx regeneration in the adult mouse. Regeneration (Oxf.) 4, 140–150 (2017).

  6. 6.

    Ide, H. Bone pattern formation in mouse limbs after amputation at the forearm level. Dev. Dyn. 241, 435–441 (2012).

  7. 7.

    Masaki, H. & Ide, H. Regeneration potency of mouse limbs. Dev. Growth Differ. 49, 89–98 (2007).

  8. 8.

    Yu, L. et al. BMP signaling induces digit regeneration in neonatal mice. Development 137, 551–559 (2010).

  9. 9.

    Heinemeier, K. M. et al. Radiocarbon dating reveals minimal collagen turnover in both healthy and osteoarthritic human cartilage. Sci. Transl. Med. 8, 346ra390 (2016).

  10. 10.

    Archer, C. W., Dowthwaite, G. P. & Francis-West, P. Development of synovial joints. Birth Defects Res. C Embryo Today 69, 144–155 (2003).

  11. 11.

    Brunet, L. J., McMahon, J. A., McMahon, A. P. & Harland, R. M. Noggin, cartilage morphogenesis, and joint formation in the mammalian skeleton. Science 280, 1455–1457 (1998).

  12. 12.

    Seemann, P. et al. Mutations in GDF5 reveal a key residue mediating BMP inhibition by NOGGIN. PLoS Genet. 5, e1000747 (2009).

  13. 13.

    Agrawal, V. et al. Epimorphic regeneration approach to tissue replacement in adult mammals. Proc. Natl Acad. Sci. USA 107, 3351–3355 (2010).

  14. 14.

    Liu, C. F., Samsa, W. E., Zhou, G. & Lefebvre, V. Transcriptional control of chondrocyte specification and differentiation. Semin. Cell Dev. Biol. 62, 34–49 (2017).

  15. 15.

    Dudhia, J. Aggrecan, aging and assembly in articular cartilage. Cell. Mol. Life Sci. 62, 2241–2256 (2005).

  16. 16.

    Murphy, J. M., Heinegard, R., McIntosh, A., Sterchi, D. & Barry, F. P. Distribution of cartilage molecules in the developing mouse joint. Matrix Biol. 18, 487–497 (1999).

  17. 17.

    Eitzinger, N. et al. Ucma is not necessary for normal development of the mouse skeleton. Bone 50, 670–680 (2012).

  18. 18.

    Zhang, Q. et al. Expression of doublecortin reveals articular chondrocyte lineage in mouse embryonic limbs. Genesis 49, 75–82 (2011).

  19. 19.

    Askary, A. et al. Ancient origin of lubricated joints in bony vertebrates. Elife 5, pii: e16415 (2016).

  20. 20.

    Kozhemyakina, E. et al. Identification of a Prg4-expressing articular cartilage progenitor cell population in mice. Arthritis Rheumatol. 67, 1261–1273 (2015).

  21. 21.

    Li, L. et al. Superficial cells are self-renewing chondrocyte progenitors, which form the articular cartilage in juvenile mice. FASEB J. 31, 1067–1084 (2017).

  22. 22.

    Rhee, D. K. et al. The secreted glycoprotein lubricin protects cartilage surfaces and inhibits synovial cell overgrowth. J. Clin. Invest. 115, 622–631 (2005).

  23. 23.

    Larson, K. M., Zhang, L., Badger, G. J. & Jay, G. D. Early genetic restoration of lubricin expression in transgenic mice mitigates chondrocyte peroxynitrite release and caspase-3 activation. Osteoarthr. Cartil. 25, 1488–1495 (2017).

  24. 24.

    Hogan, B. L. Bone morphogenetic proteins in development. Curr. Opin. Genet. Dev. 6, 432–438 (1996).

  25. 25.

    Song, J. J. et al. Bone morphogenetic protein-9 binds to liver cells and stimulates proliferation. Endocrinology 136, 4293–4297 (1995).

  26. 26.

    David, L. et al. Bone morphogenetic protein-9 is a circulating vascular quiescence factor. Circ. Res. 102, 914–922 (2008).

  27. 27.

    David, L., Mallet, C., Mazerbourg, S., Feige, J. J. & Bailly, S. Identification of BMP9 and BMP10 as functional activators of the orphan activin receptor-like kinase 1 (ALK1) in endothelial cells. Blood 109, 1953–1961 (2007).

  28. 28.

    Xu, D. J. et al. Smads, p38 and ERK1/2 are involved in BMP9-induced osteogenic differentiation of C3H10T1/2 mesenchymal stem cells. BMB Rep. 45, 247–252 (2012).

  29. 29.

    Chen, H. et al. Context-dependent signaling defines roles of BMP9 and BMP10 in embryonic and postnatal development. Proc. Natl. Acad. Sci. USA 110, 11887–11892 (2013).

  30. 30.

    Settle, S. H. Jr et al. Multiple joint and skeletal patterning defects caused by single and double mutations in the mouse Gdf6 and Gdf5 genes. Dev. Biol. 254, 116–130 (2003).

  31. 31.

    Dy, P. et al. Synovial joint morphogenesis requires the chondrogenic action of Sox5 and Sox6 in growth plate and articular cartilage. Dev. Biol. 341, 346–359 (2010).

  32. 32.

    Gao, Y., Lan, Y., Liu, H. & Jiang, R. The zinc finger transcription factors Osr1 and Osr2 control synovial joint formation. Dev. Biol. 352, 83–91 (2011).

  33. 33.

    Bandyopadhyay, A. et al. Genetic analysis of the roles of BMP2, BMP4, and BMP7 in limb patterning and skeletogenesis. PLoS Genet. 2, e216 (2006).

  34. 34.

    Tsuji, K. et al. BMP2 activity, although dispensable for bone formation, is required for the initiation of fracture healing. Nat. Genet. 38, 1424–1429 (2006).

  35. 35.

    Li, W., Salmon, R. M., Jiang, H. & Morrell, N. W. Regulation of the ALK1 ligands, BMP9 and BMP10. Biochem. Soc. Trans. 44, 1135–1141 (2016).

  36. 36.

    Bi, J. & Ge, S. Potential roles of BMP9 in liver fibrosis. Int. J. Mol. Sci. 15, 20656–20667 (2014).

  37. 37.

    Lamplot, J. D. et al. BMP9 signaling in stem cell differentiation and osteogenesis. Am. J. Stem Cells 2, 1–21 (2013).

  38. 38.

    van Caam, A. et al. The high affinity ALK1-ligand BMP9 induces a hypertrophy-like state in chondrocytes that is antagonized by TGFbeta1. Osteoarthr. Cartil. 23, 985–995 (2015).

  39. 39.

    Ren, X. et al. Nanoparticulate mineralized collagen scaffolds and BMP-9 induce a long-term bone cartilage construct in human mesenchymal stem cells. Adv. Healthc. Mater. 5, 1821–1830 (2016).

  40. 40.

    Majumdar, M. K., Wang, E. & Morris, E. A. BMP-2 and BMP-9 promotes chondrogenic differentiation of human multipotential mesenchymal cells and overcomes the inhibitory effect of IL-1. J. Cell. Physiol. 189, 275–284 (2001).

  41. 41.

    Cheng, A., Gustafson, A. R., Schaner Tooley, C. E. & Zhang, M. BMP-9 dependent pathways required for the chondrogenic differentiation of pluripotent stem cells. Differentiation 92, 298–305 (2016).

  42. 42.

    Ntumba, K., Akla, N., Oh, S. P., Eichmann, A. & Larrivee, B. BMP9/ALK1 inhibits neovascularization in mouse models of age-related macular degeneration. Oncotarget 7, 55957–55969 (2016).

  43. 43.

    Hu, N. et al. BMP9-regulated angiogenic signaling plays an important role in the osteogenic differentiation of mesenchymal progenitor cells. J. Cell Sci. 126, 532–541 (2013).

  44. 44.

    Yu, L. et al. Angiogenesis is inhibitory for mammalian digit. Regeneration (Oxf.) 1, 33–46 (2014).

  45. 45.

    Huang, K. et al. Cartilage tissue regeneration: the roles of cells, stimulating factors and scaffolds. Curr. Stem Cell Res. Ther. 13, 547–567 (2018).

  46. 46.

    Lee, J. et al. SDF-1alpha/CXCR4 signaling mediates digit tip regeneration promoted by BMP-2. Dev. Biol. 382, 98–109 (2013).

  47. 47.

    Han, M., Yang, X., Lee, J., Allan, C. H. & Muneoka, K. Development and regeneration of the neonatal digit tip in mice. Dev. Biol. 315, 125–135 (2008).

  48. 48.

    Humason, G. L. Animal Tissue Techniques. A Series of Biology Books (W.H. Freeman, San Francisco, 1962).

  49. 49.

    Junqueira, L. C., Bignolas, G. & Brentani, R. R. Picrosirius staining plus polarization microscopy, a specific method for collagen detection in tissue sections. Histochem. J. 11, 447–455 (1979).

  50. 50.

    Fernando, W. A. et al. Wound healing and blastema formation in regenerating digit tips of adult mice. Dev. Biol. 350, 301–310 (2011).

  51. 51.

    Doube, M. et al. BoneJ: Free and extensible bone image analysis in Image. J. Bone 47, 1076–1079 (2010).

Download references


We thank Regina Brunauer and Rosalie Anderson for comments on the manuscript, and members of the Muneoka Laboratory (past and present) for thoughtful discussions. We thank the referees for their thoughtful comments. The research is funded by W911NF-06-1-0161 from DARPA, W911NF-09-1-0305 from the US Army Research Center, the John L. and Mary Wright Ebaugh Endowment Fund at Tulane University and Texas A&M University.

Author information

Author notes

  1. These authors contributed equally: Ling Yu, Lindsay A. Dawson.


  1. Department of Veterinary Physiology and Pharmacology, Texas A&M University, College Station, TX, 77843, USA

    • Ling Yu
    • , Lindsay A. Dawson
    • , Mingquan Yan
    • , Katherine Zimmel
    • , Yu-Lieh Lin
    • , Connor P. Dolan
    •  & Ken Muneoka
  2. Department of Cell & Molecular Biology, Tulane University, New Orleans, LA, 70118, USA

    • Manjong Han
    •  & Ken Muneoka


  1. Search for Ling Yu in:

  2. Search for Lindsay A. Dawson in:

  3. Search for Mingquan Yan in:

  4. Search for Katherine Zimmel in:

  5. Search for Yu-Lieh Lin in:

  6. Search for Connor P. Dolan in:

  7. Search for Manjong Han in:

  8. Search for Ken Muneoka in:


Experimental design: L.Y., M.H., L.A.D. and K.M.; animal studies: L.Y., M.Y. and L.A.D.; histology: K.Z., Y.-L.L. and C.P.D.; immunohistochemistry: M.Y., L.A.D. and C.P.D.; in situ hybridization: L.Y. and M.Y.; data analysis: L.Y., M.H., L.A.D. and K.M.; manuscript writing: K.M., L.Y. and L.A.D.

Competing interests

K.M., L.Y. and M.Y. disclose patent no. 9,833,481 B2 (4104-1) on BMP9-induced articular cartilage regeneration. The authors declare no competing interests.

Corresponding author

Correspondence to Ken Muneoka.

Supplementary information

About this article

Publication history






By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.